Category Archive: Controlled release

Aug 21

Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa

Categories:

Antimicrobial, Berthiaume Institute for Precision Health, Controlled release, Uncategorized

Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH https://doi.org/10.1093/milmed/usae079

Tags: antibacterial, Berthiaume Institute for Precision Health, multidrug resistance

NIH Funding Opportunities

Notice of Change to Funding Opportunity: RFA-HS-24-004 State-based Healthcare Extension Cooperatives to Accelerate Implementation of Actionable Knowledge into Practice September 26, 2024
Notice NOT-HS-24-026 from the NIH Guide for Grants and Contracts
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) September 26, 2024
Funding Opportunity RFA-MH-26-120 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity Announcement (NOFO) from the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is intended to support establishment of facilities at minority-serving institutions (MSIs) and Institutional Development Award (IDeA)-eligible institutions for scaled production and distribution of brain cell type-specific […]
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) September 26, 2024
Funding Opportunity RFA-NS-25-024 from the NIH Guide for Grants and Contracts. The National Institute of Neurological Disorders and Stroke (NINDS) and the Office of the Director, National Institutes of Health (OD), intend to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for the conduct of scientific research utilizing data […]
Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed) September 26, 2024
Funding Opportunity RFA-DK-25-022 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) requests applications for Recruitment Sites (RS) to enroll adult and/or pediatric patients with Type 1 diabetes (T1D) with, or at high risk of, diabetic nephropathy into a longitudinal cohort study and perform protocol-based research kidney biopsies. These T1D […]
Notice of Special Interest (NOSI): Administrative Supplement for Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional) September 26, 2024
Notice NOT-AI-24-075 from the NIH Guide for Grants and Contracts
Notice of Special Interest (NOSI): Effectiveness of Mobile Health Clinics to Advance Health Equity September 26, 2024
Notice NOT-MD-24-022 from the NIH Guide for Grants and Contracts
National Evaluation Center (NEC) for AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (U19) September 26, 2024
Funding Opportunity RFA-HS-24-005 from the NIH Guide for Grants and Contracts. This NOFO invites applications for a National Evaluation Center (NEC) to evaluate AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (Healthcare Extension Service). The Healthcare Extension Service will accelerate dissemination and implementation of patient-centered outcomes research (PCOR) evidence into healthcare delivery through improvements […]
National Coordinating Center (NCC) for AHRQs Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54) September 26, 2024
Funding Opportunity RFA-HS-24-006 from the NIH Guide for Grants and Contracts. This NOFO invites applications for a National Coordinating Center (NCC) to provide support and guidance to AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (Healthcare Extension Service). The NCC will provide a wide range of services in 4 main areas: 1) technical assistance, […]
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) September 25, 2024
Funding Opportunity PAR-25-051 from the NIH Guide for Grants and Contracts. The Blueprint Neurotherapeutics Network (BPN) invites applications from neuroscience investigators seeking support to advance their small molecule drug discovery and development projects into the clinic. Participants in the BPN are responsible for conducting all studies that involve disease- or target-specific assays, models, and other […]
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) September 25, 2024
Notice NOT-NS-24-085 from the NIH Guide for Grants and Contracts

Nallathamby Laboratory

Modular and scalable nanotechnology for imaging, sensing and therapeutics

Category Archive: Controlled release

Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa

Recent Posts

Recent Comments

Archives

Categories

Meta

NIH Funding Opportunities

Copyright